Dr Yavagal shares experience of first 2 patients receiving IA allogenic mesenchymal stem cells at Jackson Memorial for Locked-In Syndrome post EVT @SVIN24. Interesting follow-up data shared from patient#1 recovery over 2y.

Honored to have contributed to this work, now published in Stroke AHA/ASA ! Grateful for the opportunity to be part of such important research 👏 Cerebrovascular & Neurointerventional Lab Mouhammad Jumaa

#MTAS is the first step in the solution to the grim problem that #MTGLASS showed us all: a devastatingly low access to disability reversing and life saving stroke Thrombectomy.

Could a deep learning algorithm make stroke triage faster and more accessible? Our study shows how Methinks Ischemia Core can match advance imaging in estimating infarct core volume using NCCT 🧵 by Anderson Brito #Stroke #NeurologyIowa #MachineLearning ahajournals.org/doi/10.1161/SV…

💡 Can flow diverters improve outcomes for remnant intracranial aneurysms (IAs)? A new subanalysis from the SEASE Registry explores the effectiveness and safety of the Surpass Evolve device for previously treated IAs. Here's what they found 👇. A 🧵by Leonardo Cruz-Criollo 1/5

Our article published at Neurology Journal has been featured on #BloggingStroke Honored to contribute to the discussion on stroke research. Cerebrovascular & Neurointerventional Lab

This SELECT 2 sub analysis supports EVT for patients with large core stroke and extracranial ICA occlusions. Many thanks to Amrou Sarraj PI of SELECT2 and his team supporting this study. Cerebrovascular & Neurointerventional Lab thank you for the opportunity to participate. neurology.org/doi/10.1212/WN…

Congratulations Cerebrovascular & Neurointerventional Lab Aaron Rodriguez Calienes on leading this important analysis to shed light on management of extracranial ICA occlusion sub population.

Our review highlights ICAS-LVO mimics with detailed illustrations, emphasizing the need for improved and standardized criteria. Establishing clear definitions is crucial for future trial development and better patient outcomes. Cerebrovascular & Neurointerventional Lab Fazeel M Siddiqui

Working with Dileep R. Yavagal, I’ve seen his dedication to stroke research firsthand. He’s a finalist for the AHA/ASA 2025 Stroke Hero Awards! Vote here: stroke.org/en/help-and-su…

Patients presenting with NIHSS >20 and large core did not benefit from EVT. Analysis of ANGEL ASPECTS trial. Learn this and much more Stroke AHA/ASA strokealert podcast.

A stroke will impact 1 in 5 people >25. The 500-fold disparity in access to life-saving thrombectomy and <5% worldwide access is a global shame. We MUST advocate to end this "Thrombectomy Desert" and ensure 50% minimum access worldwide by 2030. Ambitious but can be done